
GLP-1 Risks Explained Simply
You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
US Name:
Ultibro Breezhaler
Alternative Names:
Ultibro Breezhaler
Active Ingredients:
Indacaterol and Glycopyrronium Bromide
Brand Manufacturer:
Novartis
Manufacturer Location:
Switzerland, Spain
Click here to view Product Insert
Click here to view Product Insert
For visual reference only; actual product may vary
Ultibro Breezhaler is an inhaled prescription medicine for the long-term management of chronic obstructive pulmonary disease (COPD) in adults. It combines two bronchodilators to relax airway muscles, helping you breathe more easily for a full 24 hours with just one daily dose.
| Ultibro Breezhaler Brand | 110/50mcg 30 Inhalation Capsules |
-
|
Our price: $96.00 |
Ultibro Breezhaler is a prescription maintenance inhaler used once daily by adults with chronic obstructive pulmonary disease (COPD). This medication helps manage symptoms over the long term. It is not intended for use as a rescue inhaler for sudden breathing problems. COPD is a group of lung diseases that includes chronic bronchitis and emphysema. These conditions cause blocked airflow and make it difficult to breathe. Ultibro Breezhaler contains a dry powder medication in capsules. These capsules are used only with the special Breezhaler inhalation device. This ensures the medicine is delivered directly to your lungs.
Ultibro Breezhaler works by combining two different medicines that help relax the muscles around the airways in your lungs. The first ingredient is indacaterol. It is a long-acting beta-agonist (LABA). Indacaterol signals the airway muscles to relax and widen. The second ingredient is glycopyrronium. It is a long-acting muscarinic antagonist (LAMA). Glycopyrronium works by blocking the action of chemicals that cause airway muscles to tighten. Together, these two ingredients provide 24 hours of improved airflow. This dual action helps keep the airways open, making it easier for you to breathe all day.
Ultibro Breezhaler is intended for adults who have a diagnosis of COPD and need a long-term, daily maintenance treatment. This medication is suitable for patients with chronic bronchitis or emphysema. It is designed for individuals who can correctly follow the instructions for using a dry powder inhaler. Ultibro Breezhaler is not for everyone. It should not be used to treat asthma. It is also not for children under 18. You should tell your doctor about your medical history. This includes any heart problems, glaucoma, or urinary retention issues before you start treatment.
Ultibro Breezhaler dosage is the inhalation of the contents of one capsule, once every day. You should take your dose at the same time each day to maintain its effect. The capsules must only be used with the Breezhaler device included with your prescription. To take a dose, you place one capsule into the device. You then press buttons to pierce the capsule and inhale the powder deeply. Never swallow the capsules. If you miss a dose, take it as soon as you remember. Do not take more than one dose in a single day.
Ultibro Breezhaler may cause side effects, though not everyone will experience them. It is important to know what to watch for. Common side effects can include a stuffy or runny nose, sore throat, and headache. Some users may also experience a cough, dizziness, or a rapid heartbeat. Less common but more serious side effects can occur. These include new or worsened eye problems like glaucoma or difficulty urinating. Tell your doctor if you have any side effect that bothers you or does not go away. For severe breathing difficulty right after inhalation, seek immediate medical care.
IsraelPharm provides a simple and affordable way to get your prescription medications like Ultibro Breezhaler. We are committed to high standards of patient safety and care. Our team of licensed pharmacists ensures that every medication we dispense is genuine and of the highest quality. We source brand-name drugs from trusted manufacturers, offering them at lower prices. This helps you manage your health without financial stress. With discreet packaging and reliable international shipping, ordering your COPD treatment is convenient and secure. Trust IsraelPharm for your long-term health needs.
This is not a complete list of all possible side effects. Please consult your doctor for medical advice. Common side effects of Ultibro Breezhaler may include:
Contact your doctor if these symptoms become severe or do not go away. Seek immediate medical attention for signs of a serious allergic reaction or sudden breathing problems after use.
Ultibro Breezhaler is indicated for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including:
Ultibro Breezhaler begins to work within about 5 to 15 minutes after inhalation, helping to open the airways. However, it is designed for long-term maintenance, not for immediate relief of sudden symptoms. You should notice improved breathing and fewer flare-ups over time with consistent daily use as prescribed by your doctor.
Ultibro Breezhaler is not a steroid. It is a combination bronchodilator containing two active ingredients: indacaterol, a long-acting beta2-agonist (LABA), and glycopyrronium, a long-acting muscarinic antagonist (LAMA). These medicines work by relaxing airway muscles, unlike steroids an which primarily reduce inflammation.
Ultibro Breezhaler should not be used for an asthma attack or for sudden breathing problems. It is a long-term maintenance medication for COPD. You should always use a separate rescue inhaler, such as albuterol, for rapid relief of acute symptoms as directed by your healthcare provider.
If you miss a dose of Ultibro Breezhaler, you should take it as soon as you remember that day. However, do not take more than one dose in a 24-hour period. You should skip the missed dose if it is almost time for your next scheduled dose and resume your regular daily schedule.
It is not required to rinse your mouth after using Ultibro Breezhaler, as it is not an inhaled corticosteroid. Inhaled corticosteroids are known to sometimes cause oral thrush. However, rinsing with water after inhalation can help reduce the possibility of dry mouth or throat irritation, which are potential side effects.
Ultibro Breezhaler capsules should be stored at room temperature in a dry place. It is very important to keep the capsules in their original blister pack until you are ready to use one. Removing a capsule too early can expose it to moisture, which may make it less effective.
You should talk to your doctor about drinking alcohol while using Ultibro Breezhaler. Consuming alcohol can potentially increase the risk of certain side effects like dizziness or a rapid heartbeat. Your doctor can provide advice based on your personal health to ensure your treatment remains safe and effective.
Ultibro Breezhaler can potentially interact with other drugs, including beta-blockers, certain diuretics, and other anticholinergic medicines. It is very important that you tell your doctor about all prescription drugs, over-the-counter medications, and supplements you are taking to prevent any harmful interactions.
The main difference is that Ultibro Breezhaler contains two long-acting bronchodilators (a LAMA and a LABA). In contrast, Symbicort combines a long-acting bronchodilator (a LABA) with a corticosteroid. Ultibro is approved only for COPD, while Symbicort is prescribed for both asthma and COPD to control inflammation.
The Breezhaler device that comes with your Ultibro Breezhaler prescription is intended to be used for 30 days. You should use the new device that comes with each new pack of medicine. After you have used all the capsules in a pack, you should discard the old device and begin using the new one.
You must not swallow Ultibro Breezhaler capsules. The capsules are specially designed to be used only with the Breezhaler inhalation device. A capsule is placed inside the device, which then pierces it. This allows you to inhale the dry powder medication directly into your lungs for it to work correctly.
Ultibro Breezhaler is not typically associated with weight gain as a side effect. Its active ingredients, indacaterol and glycopyrronium, primarily affect the airways and do not commonly influence body weight. In contrast, other respiratory therapies like oral corticosteroids are sometimes linked to changes in appetite and weight.
Ultibro Breezhaler is proven to help manage COPD symptoms, improve lung function, and reduce the frequency of flare-ups. By controlling symptoms and preventing severe exacerbations, it can significantly improve quality of life. Consistent use is key to better long-term outcomes, but it has not been directly proven to extend life expectancy.
Ultibro Breezhaler may potentially affect your heart, as a rapid heartbeat (tachycardia) is a listed side effect. For this reason, patients with pre-existing cardiovascular conditions should use this medication with caution. It is important to discuss your full heart health history with your doctor before starting treatment.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and

People whose weight is higher than what is considered healthy for their height are described as having excessive body mass, clinically defined as being overweight or obese. Both of these can increase a person’s risk

The old saying “the devil is in the detail” has never been more applicable than it is right now. Multiple patients are discovering that what they regarded as straightforward access to prescribed medication once a


